KURN — Kuros Biosciences AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Kuros Biosciences AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	20.8	28.4	28.6	24.1	14.2
Net Total Accounts Receivable
Net Total Receivables	1.07	1.4	2.05	3.62	7.62
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23.3	34	32.9	31.4	27.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.78	2.59	2.45	2.32	2.64
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	87.9	94.4	91.3	82.9	71.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.64	3.88	11.3	12.6	13.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	10	9.76	14.4	14.1	14.8
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	77.9	84.6	77	68.9	56.7
Total Liabilities & Shareholders' Equity	87.9	94.4	91.3	82.9	71.5
Total Common Shares Outstanding